Here are some others; I didn't include the links because I am lazy:
Insomnia and blood circulation:
"Abstract Contrary to previous presumption, accumulated evidence indicates that far-infrared rays are biologically active. A small ceramic disk that emist far-infrared rays (4–16
m) has commonly been applied to a local spot or a whole part of the body for exposure. Pioneering attempts to experimentally analyze an effect of acute and chronic radiation of far-infrared rays on living organisms have detected a growth-promoting effect in growing rats, a sleep-modulatory effect in freely behaving rats and an insomiac patient, and a blood circulation-enhancing effect in human skin. Question-paires to 542 users of far-infrared radiator disks embedded in bedelothes revealed that the majority of the users subjectively evaluated an improvement of their health. These effects on living organisms appear to be non-specifically triggered by an exposure to far-infrared rays, which eventually induce an increase in temperature of the body tissues or, more basically, an elevated motility of body fluids due to decrease in size of water clusters."
Anti Inflammatory:
"Far Infrared Therapy Inhibits Vascular Endothelial Inflammation via the Induction of Heme Oxygenase-1
Chih-Ching Lin ; Xiao-Ming Liu ; Kelly Peyton ; Hong Wang ; Wu-Chang Yang ; Shing-Jong Lin ; and William Durante *
From the Institute of Clinical Medicine (C.-C.L., S.-J.L.), School of Medicine (C.-C.L., W.-C.Y., S.-J.L.), National Yang-Ming University, Taipei, Taiwan; the Division of Nephrology (C.-C.L., W.-C.Y.) and the Division of Cardiology (S.-J.L.), Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; the Department of Pharmacology (H.W.), Temple University, Philadelphia, Pa; and the Department of Medical Pharmacology and Physiology (K.P., W.D.), School of Medicine, University of Missouri-Columbia, Columbia, Mo.
* To whom correspondence should be addressed. E-mail:
durantew@health.missouri.edu .
Objective—Survival of arteriovenous fistulas (AVFs) in hemodialysis patients is associated with both far infrared (FIR) therapy and length polymorphisms of the heme oxygenase-1 (HO-1) promoter. In this study, we evaluated whether there is an interaction between FIR radiation and HO-1 in regulating vascular inflammation.
Methods and Results—Treatment of cultured human umbilical vein endothelial cells (ECs) with FIR radiation stimulated HO-1 protein, mRNA, and promoter activity. HO-1 induction was dependent on the activation of the antioxidant responsive element/NF-E2-related factor-2 complex, and was likely a consequence of heat stress. FIR radiation also inhibited tumor necrosis factor (TNF)-
–mediated expression of E-selectin, vascular cell adhesion molecule-1, intercellular cell adhesion molecule-1, monocyte chemoattractant protein-1, interleukin-8, and the cytokine-mediated adhesion of monocytes to ECs. The antiinflammatory action of FIR was mimicked by bilirubin, and was reversed by the HO inhibitor, tin protoporphyrin-IX, or by the selective knockdown of HO-1. Finally, the antiinflammatory effect of FIR was also observed in patients undergoing hemodialysis.
Conclusions—These results demonstrate that FIR therapy exerts a potent antiinflammatory effect via the induction of HO-1. The ability of FIR therapy to inhibit inflammation may play a critical role in preserving blood flow and patency of AVFs in hemodialysis patients."
Chronic Fatigue Syndrome:
Abstract Objective This paper describes the successful treatment of two patients with chronic fatigue syndrome (CFS) using repeated thermal therapy. Methods: Two patients with CFS underwent treatment with prednisolone (PSL), with no satisfactory effect. They were subjected to thermal therapy that consisted of a far-infrared ray dry sauna at 60 °C and postsauna warming. The therapy was performed once a day, for a total of 35 sessions. After discharge, these subjects continued the therapy once or twice a week on an outpatient basis for 1 year. Results: Symptoms such as fatigue, pain, sleep disturbance, and low-grade fever were dramatically improved after 15 to 25 sessions of thermal therapy. Although PSL administration was discontinued, the subjects showed no relapse or exacerbation of symptoms during the first year after discharge. The patients became socially rehabilitated 6 months after discharge. Conclusions These results suggest that repeated thermal therapy might be a promising method for the treatment of CFS.
Depression:
Repeated Thermal Therapy Diminishes Appetite Loss and Subjective Complaints in Mildly Depressed Patients Akinori Masuda, MD, PhD, Masamitsu Nakazato, MD, PhD, Takashi Kihara, MD, PhD, Shinichi Minagoe, MD, PhD and Chuwa Tei, MD, PhD From the Psychosomatic Medicine, Respiratory and Stress Care Center, Kagoshima University Hospital, Kagoshima, Japan (A.M.); the Department of Internal Medicine, Faculty of Medicine, Miyazaki University, Miyazaki, Japan (M.N.); and Cardiovascular, Respiratory and Metabolic Medicine, Kagoshima University, Kagoshima, Japan (T.K., S.M., C.T.).
Address correspondence and reprint requests to Akinori Masuda, MD, Psychosomatic Medicine, Respiratory and Stress Care center, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima City, 890-8520, Japan. E-mail:
masudaak@m.kufm.kagoshima-u.ac.jp Objective: We observed that repeated thermal therapy improved appetite loss and general well-being in patients with chronic heart failure. The purpose of this study is to clarify the effects of repeated thermal therapy in mildly depressed patients with appetite loss and subjective complaints.
Methods: Twenty-eight mildly depressed inpatients with general fatigue, appetite loss, and somatic and mental complaints were randomly assigned to thermal therapy group (
n = 14) or nonthermal therapy group (
n = 14). Patients in the thermal therapy group were treated with 60°C far-infrared ray dry sauna for 15 minutes and were then kept at bed rest with a blanket for 30 minutes once a day, 5 days a week for a total of 20 sessions in 4 weeks.
Results: Four weeks after admission, somatic complaints, hunger, and relaxation scores significantly improved (
p < .001,
p < .0001,
p < .0001, respectively) and mental complaints slightly improved (
p = .054) in the thermal therapy group compared with the nonthermal therapy group. Furthermore, the plasma ghrelin concentrations and daily caloric intake in the thermal therapy group significantly increased compared with the nonthermal therapy group (
p < .05).
Conclusions: These findings suggest that repeated thermal therapy may be useful for mildly depressed patients with appetite loss and subjective complaints.
SS
PS - As you may have noticed, these are all scientific papers, not from sites that sell anything.